[ Price : $8.95]
A FDA advisory committee votes against recommending approval for Lexicon Pharmaceuticals' drug Zynquista (sotagliflozin) for adult...[ Price : $8.95]
FDA backpedals on safety warnings it required on CAR-T cell therapies related to secondary cancers, according to CBER director Pet...[ Price : $8.95]
Percussionaire recalls certain lots of its Phasitron 5 breathing circuits due to the unexpected presence of nickel coating on one ...[ Price : $8.95]
FDA approves the addition of mail-back envelopes to the existing opioid analgesic risk evaluation and mitigation strategy to help ...[ Price : $8.95]
FDA brings on former Leavitt Partners consultant Amy Comstock Rick to serve as strategic coalitions director for the newly created...[ Price : $8.95]
A recent inspection of Aarti Drugs Ltds active pharmaceutical ingredient manufacturing plant in India leads to a seven-item FDA Fo...[ Price : $8.95]
Senator Marco Rubio (R-FL) urges FDA to take immediate action against two pharmaceutical companies based in Chinas Xinjiang region...[ Price : $8.95]
FDA extends by three months its review of a Syndax Pharmaceuticals NDA for revumenib and its use in treating adult and pediatric p...